Journal
REGENERATIVE MEDICINE
Volume 11, Issue 3, Pages 245-260Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/rme-2015-0045
Keywords
angiogenesis; collagen I; diabetic ulcer; extracellular matrix proteins; laminin; mesenchymal stem cells; tissue engineering; tissue scaffolds; VEGF
Categories
Funding
- Yale-UCL Medtech Initiative Flagship Project Vascular Engineering award
- NIH [R56-HL095498, R01-HL-095498]
- Yale Department of Surgery Ohse award
- BBSRC [BB/F023774/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/F023774/1] Funding Source: researchfish
Ask authors/readers for more resources
Aim: We hypothesized that delivery of mesenchymal stem cells (MSCs) in a biomimetic collagen scaffold improves wound healing in a diabetic mouse model. Materials & methods: Rolled collagen scaffolds containing MSCs were implanted or applied topically to diabetic C57BL/6 mice with excisional wounds. Results: Rolled scaffolds were hypoxic, inducing MSC synthesis and secretion of VEGF. Diabetic mice with wounds treated with rolled scaffolds containing MSCs showed increased healing compared with controls. Histologic examination showed increased cellular proliferation, increased VEGF expression and capillary density, and increased numbers of macrophages, fibroblasts and smooth muscle cells. Addition of laminin to the collagen scaffold enhanced these effects. Conclusion: Activated MSCs delivered in a biomimetic-collagen scaffold enhanced wound healing in a translationally relevant diabetic mouse model.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available